胎儿宫内心脏介入治疗（FCI）技术自1991年起发展至今，随着技术成功率的提高、并发症的减少及对患胎预后的改善，该技术已逐步获得医学界的认可与推广。国际胎儿心脏介入注册数据库的建立促进了该技术的国际间交流和技术发展，国际报道临床病例已逾400例。在国内，迄今已有广东、上海、青岛、重庆等多家医疗机构开展宫内心脏介入治疗，但病例数仍有限。文章从胎儿宫内心脏介入治疗的种类、操作过程、手术并发症、治疗指征以及治疗结局进行综述，同时提出该技术目前存在的问题和未来的展望。

Fetal cardiac intervention (FCI) has evolved since its inception in 1991. With the improvement in technical success rates, reduction in complications, and enhancement of fetal outcomes, this technique has gradually gained recognition and promotion. The establishment of the International Fetal Cardiac Intervention Registry has facilitated international exchange and technological development in this field, with over 400 clinical cases reported worldwide. In China, several medical institutions in Guangdong, Shanghai, Qingdao, Chongqing, and other regions have initiated in-utero cardiac intervention treatments, although the number of cases remains limited. This article summarized the types of fetal in-utero cardiac interventions, the procedural process, surgical complications, indications for treatment, and treatment outcomes, while also highlighting current challenges and future prospects of the technology.